Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 33,610 | 38,796 | 41,637 | 61,564 | 56,088 | -- |
| General And Administrative Expense | 33,610 | 38,796 | 41,637 | 61,564 | 56,088 | -- |
| Other Operating Expenses | 3,317 | -- | -- | -- | 2,644 | -- |
| Operating Expense | 36,927 | 38,796 | 41,637 | 61,564 | 58,732 | -- |
| Operating Income | -36,927 | -38,796 | -41,637 | -61,564 | -58,732 | -- |
| EBIT | -36,927 | -38,796 | -41,637 | -61,564 | -58,732 | -- |
| Interest Income | 0.00 | 85.00 | 68.00 | 436.00 | 1,029 | -- |
| Interest Income Non Operating | 0.00 | 85.00 | 68.00 | 436.00 | 1,029 | -- |
| Net Interest Income | 0.00 | 85.00 | 68.00 | 436.00 | 1,029 | -- |
| Pretax Income | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Net Income From Continuing Operation Net Minority Interest | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Net Income Including Noncontrolling Interests | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Net Income Common Stockholders | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Net Income | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| EBITDA | -36,927 | -38,796 | -41,637 | -61,564 | -58,732 | -- |
| Normalized EBITDA | -36,927 | -38,796 | -41,637 | -61,564 | -58,732 | -- |
| Basic EPS | -0.00 | -- | -0.00 | -0.00 | -0.00 | -- |
| Diluted EPS | -0.00 | -- | -0.00 | -0.00 | -0.00 | -- |
| Basic Average Shares | 21.9M | -- | 21.8M | 21.8M | 21.8M | -- |
| Diluted Average Shares | 21.9M | -- | 21.8M | 21.8M | 21.8M | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Diluted NI Availto Com Stockholders | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Net Income Continuous Operations | -36,927 | -38,711 | -41,569 | -61,128 | -57,703 | -- |
| Net Non Operating Interest Income Expense | 0.00 | 85.00 | 68.00 | 436.00 | 1,029 | -- |
| Other Gand A | 33,610 | 38,796 | 41,637 | 61,564 | 56,088 | -- |
| Total Expenses | 36,927 | 38,796 | 41,637 | 61,564 | 58,732 | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 62,109 | 62,202 | 5,707 | 55,397 | 104,442 | -- |
| Cash Cash Equivalents And Short Term Investments | 62,109 | 62,202 | 5,707 | 55,397 | 104,442 | -- |
| Cash Financial | 62,109 | 62,202 | 5,707 | 55,397 | 104,442 | -- |
| Receivables | 5,360 | 2,411 | 26,470 | 24,687 | 20,024 | -- |
| Prepaid Assets | 1,429 | 3,627 | 3,144 | 7,408 | 12,584 | -- |
| Current Assets | 68,898 | 68,240 | 35,321 | 87,492 | 137,050 | -- |
| Net PPE | 507,192 | 490,833 | 486,333 | 481,333 | 481,334 | -- |
| Total Non Current Assets | 507,192 | 490,833 | 486,333 | 481,333 | 481,334 | -- |
| Total Assets | 576,090 | 559,073 | 521,654 | 568,825 | 618,384 | -- |
| Current Debt | 53,658 | 51,766 | -- | -- | -- | -- |
| Current Debt And Capital Lease Obligation | 53,658 | 51,766 | -- | -- | -- | -- |
| Accounts Payable | 45,253 | 0.00 | 15,968 | 26,570 | 0.00 | -- |
| Payables | 102,884 | 30,832 | 15,968 | 26,570 | -- | 851.00 |
| Payables And Accrued Expenses | 102,884 | 50,832 | 30,968 | 36,570 | 25,000 | -- |
| Current Accrued Expenses | 0.00 | 20,000 | 15,000 | 10,000 | 25,000 | -- |
| Current Liabilities | 156,542 | 102,598 | 30,968 | 36,570 | 25,000 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 156,542 | 102,598 | 30,968 | 36,570 | 25,000 | -- |
| Common Stock | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | -- |
| Capital Stock | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | -- |
| Retained Earnings | -1.5M | -1.4M | -1.4M | -1.4M | -1.3M | -- |
| Gains Losses Not Affecting Retained Earnings | 100,356 | 100,356 | 100,356 | 100,356 | 100,356 | -- |
| Common Stock Equity | 419,548 | 456,475 | 490,686 | 532,255 | 593,384 | -- |
| Stockholders Equity | 419,548 | 456,475 | 490,686 | 532,255 | 593,384 | -- |
| Total Equity Gross Minority Interest | 419,548 | 456,475 | 490,686 | 532,255 | 593,384 | -- |
| Total Capitalization | 419,548 | 456,475 | 490,686 | 532,255 | 593,384 | -- |
| Net Tangible Assets | 419,548 | 456,475 | 490,686 | 532,255 | 593,384 | -- |
| Tangible Book Value | 419,548 | 456,475 | 490,686 | 532,255 | 593,384 | -- |
| Working Capital | -87,644 | -34,358 | 4,353 | 50,922 | 112,050 | -- |
| Invested Capital | 473,206 | 508,241 | 490,686 | 532,255 | 593,384 | -- |
| Total Debt | 53,658 | 51,766 | -- | -- | -- | -- |
| Share Issued | 21.9M | 21.9M | 21.8M | 21.8M | 21.8M | -- |
| Ordinary Shares Number | 21.9M | 21.9M | 21.8M | 21.8M | 21.8M | -- |
| Dueto Related Parties Current | 57,631 | 30,832 | -- | -- | -- | 0.00 |
| Other Current Borrowings | 53,658 | 51,766 | -- | -- | -- | -- |
| Taxes Receivable | 5,360 | 2,411 | 26,470 | 24,687 | 20,024 | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 16,266 | 6,495 | -44,690 | -50,229 | -55,171 | -- |
| Cash Flow From Continuing Operating Activities | 16,266 | 6,495 | -44,690 | -50,229 | -55,171 | -- |
| Change In Working Capital | 51,301 | 43,440 | -3,121 | 10,900 | 2,532 | -- |
| Changes In Account Receivables | -- | -- | -- | -- | -2,094 | -- |
| Change In Receivables | -2,949 | 24,059 | -1,783 | -4,663 | -2,094 | -- |
| Change In Payables And Accrued Expense | 52,052 | 19,864 | -5,602 | 11,570 | 4,149 | -- |
| Change In Payable | 52,052 | -- | -- | -- | 4,149 | -- |
| Other Non Cash Items | 1,892 | -- | -- | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- | -115,189 |
| Purchase Of PPE | -- | -- | -- | -- | -- | -115,189 |
| Net PPE Purchase And Sale | 21,851 | 101,742 | 0.00 | 1,184 | 0.00 | -- |
| Investing Cash Flow | -16,359 | 0.00 | -5,000 | 1,184 | -1,179 | -- |
| Cash Flow From Continuing Investing Activities | -16,359 | 0.00 | -5,000 | 1,184 | -1,179 | -- |
| Changes In Cash | -93.00 | 56,495 | -49,690 | -49,045 | -56,350 | -- |
| Beginning Cash Position | 62,202 | 5,707 | 55,397 | 104,442 | 160,792 | -- |
| End Cash Position | 62,109 | 62,202 | 5,707 | 55,397 | 104,442 | -- |
| Free Cash Flow | 16,266 | 1,495 | -44,690 | -50,229 | -55,171 | -- |
| Change In Account Payable | 25,253 | -- | -- | -- | 4,149 | -- |
| Change In Prepaid Assets | 2,198 | -483.00 | 4,264 | 3,993 | 477.00 | -- |
| Net Income From Continuing Operations | -36,927 | -38,711 | -41,569 | -61,129 | -57,703 | -- |
| Net Other Investing Changes | -38,210 | -101,742 | -5,000 | 0.00 | -1,179 | -- |
| Sale Of PPE | 21,851 | 106,742 | 0.00 | 1,184 | 0.00 | -- |